Cas receives additional regulatory input from NSP family proteins, including BCAR3 (breast cancer anti-estrogen resistance 3, also called AND-34, NSP2, Sh2d3b) (Wallez et al., 2012). Here, BCAR3 is linked to breast carcinoma.